Patent · US Active

Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same

US10870639B2 · kind B2 · utility

2Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 26, 2019
Grant dateDec 22, 2020
Priority date
Expiry dateApr 26, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/506
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are a pyrimidine compound represented by Formula 1, a method of preparing the compound, and a pharmaceutical use of the compound for the prevention or treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.